Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Century Therapeutics initiated with an Outperform at SVB Leerink » 08:47
07/13/21
07/13
08:47
07/13/21
08:47
IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch initiated coverage of Century Therapeutics with an Outperform rating and $33 price target. The analyst believes Century Therapeutics has a cell therapy platform that could prove transformative. Foundational to its approach is dedication to allogenic, induced pluripotent stem cells and passive allo-evasion. Graybosch thinks these two elements bring the flexibility in product development necessary for success across tumor indications and care settings. Compared to other allogenic sources, the analyst believes iPSC is best suited for optimization of functionality across multiple dimensions in parallel, which will be necessary for breadth in success.

ShowHide Related Items >><<
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

07/13/21 JPMorgan
Century Therapeutics initiated with an Overweight at JPMorgan
07/13/21 BofA
BofA starts Century Therapeutics at Buy with $34 price target
07/13/21 BofA
Century Therapeutics initiated with a Buy at BofA
07/13/21 Piper Sandler
Century Therapeutics initiated with an Overweight at Piper Sandler
  • 18
    Jun
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

Initiation
Century Therapeutics initiated with an Overweight at JPMorgan » 08:36
07/13/21
07/13
08:36
07/13/21
08:36
IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

JPMorgan analyst Eric…

JPMorgan analyst Eric Joseph initiated coverage of Century Therapeutics with an Overweight rating and $40 price target. The analyst believes Century's induced pluripotent stem cell platform, with its novel Allo-Evasion technology, is "uniquely equipped" to address some of the challenges presented in the manufacture of donor-derived products, in particular complex genetic engineering, consistency and efficient scalability. He believes the self-renewing capacity of iPSCs could offer potential for multiple cell modifications and improved CAR cell persistency relative to other donor-derived candidates.

ShowHide Related Items >><<
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

07/13/21 BofA
BofA starts Century Therapeutics at Buy with $34 price target
07/13/21 BofA
Century Therapeutics initiated with a Buy at BofA
07/13/21 Piper Sandler
Century Therapeutics initiated with an Overweight at Piper Sandler
  • 18
    Jun
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

Initiation
BofA starts Century Therapeutics at Buy with $34 price target » 07:47
07/13/21
07/13
07:47
07/13/21
07:47
IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

As previously reported,…

As previously reported, BofA analyst Geoff Meacham initiated coverage of Century Therapeutics with a Buy rating and $34 price target. Century's platform uses induced pluripotent stem cells, or iPSCs, to develop chimeric antigen receptor-NK cells and CAR-T cells s for oncology, noted Meacham. Century is "one of just a few companies pushing the leading edge of NK cell therapy" and its platform could be "among the leaders in the gene / cell therapy space," added the analyst.

ShowHide Related Items >><<
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

07/13/21 BofA
Century Therapeutics initiated with a Buy at BofA
07/13/21 Piper Sandler
Century Therapeutics initiated with an Overweight at Piper Sandler
  • 18
    Jun
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

Initiation
Century Therapeutics initiated with a Buy at BofA » 06:11
07/13/21
07/13
06:11
07/13/21
06:11
IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

BofA initiated coverage…

BofA initiated coverage of Century Therapeutics with a Buy rating and $34 price target.

ShowHide Related Items >><<
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

07/13/21 Piper Sandler
Century Therapeutics initiated with an Overweight at Piper Sandler
  • 18
    Jun
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

Initiation
Century Therapeutics initiated with an Overweight at Piper Sandler » 04:47
07/13/21
07/13
04:47
07/13/21
04:47
IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

, FATE

Fate Therapeutics

$85.91 /

-4.48 (-4.96%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff initiated coverage of Century Therapeutics (IPSC) with an Overweight rating and $38 price target. Century is developing a pipeline of differentiated iNK and iT cell therapies with four investigational new drugs over the next three years, Tenthoff tells investors in a research note. The analyst sees Fate Therapeutics (FATE) as Century's closest comp and believes there is opportunity for Century to "close the valuation gap" by advancing its cell therapies into the clinic, reporting data and signing new partnerships.

ShowHide Related Items >><<
FATE Fate Therapeutics
$85.91 /

-4.48 (-4.96%)

IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

FATE Fate Therapeutics
$85.91 /

-4.48 (-4.96%)

06/11/21 BMO Capital
Fate Therapeutics coverage transferred at BMO Capital
06/07/21 H.C. Wainwright
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
06/04/21 Roth Capital
Fate Therapeutics duration response remains unknown, says Roth Capital
06/04/21 Piper Sandler
Fate's Phase I data showed 8 patients achieved ORR, says Piper Sandler
FATE Fate Therapeutics
$85.91 /

-4.48 (-4.96%)

  • 18
    Jun
  • 06
    Jan
IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

FATE Fate Therapeutics
$85.91 /

-4.48 (-4.96%)

On The Fly
Opening Day: Moving iMage moves up on market debut » 08:12
07/10/21
07/10
08:12
07/10/21
08:12
SNTG

Sentage

$34.25 /

-13.75 (-28.65%)

, RNAZ

Transcode Therapeutics

$5.26 /

-0.74 (-12.33%)

, AGRI

AgriFORCE Growing Systems

$5.60 /

+0.82 (+17.15%)

, MITQ

Moving iMage

$16.10 /

-7.28 (-31.14%)

, LDOC

LinkDoc Technology

/

+

, DIDI

DiDi

$12.04 /

+0.815 (+7.26%)

, BABA

Alibaba

$206.00 /

+6.04 (+3.02%)

, CYT

Cyteir Therapeutics

$18.70 /

+0.185 (+1.00%)

, FEMY

Femasys

$7.29 /

+0.02 (+0.28%)

, DNAY

Codex DNA

$17.23 /

-0.06 (-0.35%)

, AMAM

Ambrx Biopharma

$21.67 /

+0.68 (+3.24%)

, TRMR

Tremor International

$20.98 /

+2.06 (+10.89%)

, ATAI

Atai Life Sciences

$18.62 /

-1.06 (-5.39%)

, IPSC

Century Therapeutics

$27.35 /

+0.69 (+2.59%)

, VERV

Verve Therapeutics

$46.11 /

-0.09 (-0.19%)

, LYEL

Lyell Immunopharma

$15.87 /

+0.62 (+4.07%)

, ISPC

iSpecimen

$6.48 /

+0.13 (+2.05%)

, HOOD

Robinhood

/

+

, RGCB

Regencell Bioscience

/

+

, QNIU

Qiniu

/

+

, CMSL

Camposol

/

+

, SPRK

Spark Education

/

+

, BLND

Blend

/

+

, SCAN

Perspectum Group

/

+

, VTEX

VTEX

/

+

, GAMB

Gambling.com

/

+

, DUOL

Duolingo

/

+

, AUTH

Authentic Brands Group

$8.01 /

+ (+0.00%)

, RXST

RxSIGHT

/

+

Shares of Moving iMage…

ShowHide Related Items >><<
VERV Verve Therapeutics
$46.11 /

-0.09 (-0.19%)

HOOD Robinhood
/

+

DNAY Codex DNA
$17.23 /

-0.06 (-0.35%)

DIDI DiDi
$12.04 /

+0.815 (+7.26%)

CYT Cyteir Therapeutics
$18.70 /

+0.185 (+1.00%)

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

AMAM Ambrx Biopharma
$21.67 /

+0.68 (+3.24%)

SNTG Sentage
$34.25 /

-13.75 (-28.65%)

RNAZ Transcode Therapeutics
$5.26 /

-0.74 (-12.33%)

AGRI AgriFORCE Growing Systems
$5.60 /

+0.82 (+17.15%)

MITQ Moving iMage
$16.10 /

-7.28 (-31.14%)

LDOC LinkDoc Technology
/

+

DIDI DiDi
$12.04 /

+0.815 (+7.26%)

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

07/08/21 Mizuho
Alibaba core EBITA estimates look 10% too high, says Mizuho
07/07/21 Needham
Alibaba may see deceleration in retail sales, says Needham
07/07/21 KeyBanc
Alibaba price target lowered to $270 from $275 at KeyBanc
07/06/21 HSBC
Alibaba price target lowered to $270 from $288 at HSBC
CYT Cyteir Therapeutics
$18.70 /

+0.185 (+1.00%)

FEMY Femasys
$7.29 /

+0.02 (+0.28%)

DNAY Codex DNA
$17.23 /

-0.06 (-0.35%)

AMAM Ambrx Biopharma
$21.67 /

+0.68 (+3.24%)

TRMR Tremor International
$20.98 /

+2.06 (+10.89%)

ATAI Atai Life Sciences
$18.62 /

-1.06 (-5.39%)

07/08/21 Aegis
Atai Life Sciences initiated with a Buy at Aegis
IPSC Century Therapeutics
$27.35 /

+0.69 (+2.59%)

VERV Verve Therapeutics
$46.11 /

-0.09 (-0.19%)

LYEL Lyell Immunopharma
$15.87 /

+0.62 (+4.07%)

06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
ISPC iSpecimen
$6.48 /

+0.13 (+2.05%)

HOOD Robinhood
/

+

RGCB Regencell Bioscience
/

+

QNIU Qiniu
/

+

CMSL Camposol
/

+

SPRK Spark Education
/

+

BLND Blend
/

+

SCAN Perspectum Group
/

+

VTEX VTEX
/

+

GAMB Gambling.com
/

+

DUOL Duolingo
/

+

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

RXST RxSIGHT
/

+

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

  • 16
    Jul
  • 08
    Jul
  • 09
    Jul
  • 08
    Jul
  • 30
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 17
    Jun
LDOC LinkDoc Technology
/

+

HOOD Robinhood
/

+

DIDI DiDi
$12.04 /

+0.815 (+7.26%)

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

AUTH Authentic Brands Group
$8.01 /

+ (+0.00%)

SNTG Sentage
$34.25 /

-13.75 (-28.65%)

RGCB Regencell Bioscience
/

+

LDOC LinkDoc Technology
/

+

HOOD Robinhood
/

+

DIDI DiDi
$12.04 /

+0.815 (+7.26%)

CYT Cyteir Therapeutics
$18.70 /

+0.185 (+1.00%)

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

DIDI DiDi
$12.04 /

+0.815 (+7.26%)

BABA Alibaba
$206.00 /

+6.04 (+3.02%)

ATAI Atai Life Sciences
$18.62 /

-1.06 (-5.39%)

Over a month ago
On The Fly
Opening Day: WalkMe stock price falls following $287M IPO » 08:34
06/19/21
06/19
08:34
06/19/21
08:34
CYT

Cyteir Therapeutics

$17.18 /

+0.18 (+1.06%)

, FEMY

Femasys

$12.45 /

-0.79 (-5.97%)

, AMAM

Ambrx Biopharma

$17.60 /

-0.26 (-1.46%)

, DNAY

Codex DNA

$19.06 /

+0.45 (+2.42%)

, TRMR

Tremor International

$17.92 /

+ (+0.00%)

, ATAI

Atai Life Sciences

$19.50 /

+ (+0.00%)

, IPSC

Century Therapeutics

$22.46 /

+2.98 (+15.30%)

, RERE

AiHuiShou

$16.80 /

-1.56 (-8.50%)

, VERV

Verve Therapeutics

$38.76 /

+7.115 (+22.49%)

, LYEL

Lyell Immunopharma

$16.20 /

-0.6 (-3.57%)

, ISPC

iSpecimen

$7.40 /

+0.29 (+4.08%)

, WKME

WalkMe

$28.83 /

-0.17 (-0.59%)

, MOLN

Molecular Partners

$19.29 /

-0.59 (-2.97%)

, CNVY

Convey Holding Parent

$12.20 /

-0.505 (-3.97%)

, ALZN

Alzamend Neuro

$9.01 /

-1.01 (-10.08%)

, FLYW

Flywire

$33.80 /

+1.45 (+4.48%)

, PAY

Paymentus

$29.20 /

-0.53 (-1.78%)

, ZIP

ZipRecruiter

$21.26 /

+0.56 (+2.71%)

, DAWN

Day One Biopharmaceuticals

$21.42 /

+2.1899 (+11.39%)

, FIGS

Figs

$36.55 /

+0.04 (+0.11%)

, OMIC

Singular Genomics

$23.90 /

-0.34 (-1.40%)

, CNTA

Centessa

$24.87 /

-0.57 (-2.24%)

, DIDI

DiDi

$14.23 /

-2.43 (-14.59%)

, QNIU

Qiniu

/

+

, RGCB

Regencell Bioscience

/

+

, ELEV

Elevation Oncology

$13.25 /

+0.61 (+4.83%)

, CMSL

Camposol

/

+

, DNUT

Krispy Kreme

/

+

, YOU

Clear Secure

$42.88 /

+4.28 (+11.09%)

, GS

Goldman Sachs

$348.74 /

-12.86 (-3.56%)

, MS

Morgan Stanley

$84.05 /

-3.86 (-4.39%)

, JPM

JPMorgan

$147.87 /

-3.92 (-2.58%)

, AMZN

Amazon.com

$3,486.78 /

-7.155 (-0.20%)

, F

Ford

$14.52 /

-0.25 (-1.69%)

, SAFO

Save Foods

/

+

, HOOD

Robinhood

/

+

Backed by Insight Venture…

ShowHide Related Items >><<
WKME WalkMe
$28.83 /

-0.17 (-0.59%)

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

FLYW Flywire
$33.80 /

+1.45 (+4.48%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

CYT Cyteir Therapeutics
$17.18 /

+0.18 (+1.06%)

FEMY Femasys
$12.45 /

-0.79 (-5.97%)

AMAM Ambrx Biopharma
$17.60 /

-0.26 (-1.46%)

DNAY Codex DNA
$19.06 /

+0.45 (+2.42%)

TRMR Tremor International
$17.92 /

+ (+0.00%)

ATAI Atai Life Sciences
$19.50 /

+ (+0.00%)

IPSC Century Therapeutics
$22.46 /

+2.98 (+15.30%)

RERE AiHuiShou
$16.80 /

-1.56 (-8.50%)

VERV Verve Therapeutics
$38.76 /

+7.115 (+22.49%)

LYEL Lyell Immunopharma
$16.20 /

-0.6 (-3.57%)

06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
ISPC iSpecimen
$7.40 /

+0.29 (+4.08%)

WKME WalkMe
$28.83 /

-0.17 (-0.59%)

MOLN Molecular Partners
$19.29 /

-0.59 (-2.97%)

06/21/21 H.C. Wainwright
Molecular Partners assumed with a Buy at H.C. Wainwright
CNVY Convey Holding Parent
$12.20 /

-0.505 (-3.97%)

ALZN Alzamend Neuro
$9.01 /

-1.01 (-10.08%)

FLYW Flywire
$33.80 /

+1.45 (+4.48%)

06/21/21
Fly Intel: Top five analyst initiations
06/21/21 JPMorgan
Flywire initiated with an Overweight at JPMorgan
06/21/21 Raymond James
Flywire initiated with an Outperform at Raymond James
06/21/21 Raymond James
Flywire initiated with an Outperform at Raymond James
PAY Paymentus
$29.20 /

-0.53 (-1.78%)

06/21/21 JPMorgan
Paymentus initiated with a Neutral at JPMorgan
06/21/21 Raymond James
Paymentus initiated with an Outperform at Raymond James
06/21/21 Baird
Paymentus risk/reward seen positive, Baird starts with Outperform
06/21/21 Wells Fargo
Paymentus initiated with an Overweight at Wells Fargo
ZIP ZipRecruiter
$21.26 /

+0.56 (+2.71%)

06/21/21 JPMorgan
ZipRecruiter initiated with a Neutral at JPMorgan
06/21/21 Evercore ISI
Evercore ISI starts 'differentiated' ZipRecruiter at Outperform
06/21/21 Raymond James
ZipRecruiter initiated with a Strong Buy at Raymond James
DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

06/21/21 Cowen
Cowen starts Day One with Outperform on glioma potential
06/21/21 JPMorgan
Day One Biopharmaceuticals initiated with an Overweight at JPMorgan
06/21/21 Wedbush
Day One Biopharmaceuticals initiated with an Outperform at Wedbush
06/21/21 Wedbush
Day One Biopharmaceuticals initiated with an Outperform at Wedbush
FIGS Figs
$36.55 /

+0.04 (+0.11%)

06/21/21 Guggenheim
Figs initiated with a Buy at Guggenheim
06/21/21 Cowen
Cowen starts Figs at Outperform, sees path to market cap over $8B
06/21/21 Cowen
Figs initiated with an Outperform at Cowen
OMIC Singular Genomics
$23.90 /

-0.34 (-1.40%)

06/21/21 Cowen
Cowen starts 'promising' Singular Genomics with Outperform rating
06/21/21 JPMorgan
Singular Genomics initiated with an Overweight at JPMorgan
06/21/21 BofA
Singular Genomics initiated with a Neutral at BofA
06/21/21 Cowen
Singular Genomics initiated with an Outperform at Cowen
CNTA Centessa
$24.87 /

-0.57 (-2.24%)

06/22/21
Fly Intel: Top five analyst initiations
06/22/21 Jefferies
Centessa initiated with a Buy at Jefferies
06/22/21 Morgan Stanley
Centessa initiated with an Overweight at Morgan Stanley
06/22/21 Goldman Sachs
Centessa initiated with a Buy at Goldman Sachs
DIDI DiDi
$14.23 /

-2.43 (-14.59%)

QNIU Qiniu
/

+

RGCB Regencell Bioscience
/

+

ELEV Elevation Oncology
$13.25 /

+0.61 (+4.83%)

CMSL Camposol
/

+

DNUT Krispy Kreme
/

+

YOU Clear Secure
$42.88 /

+4.28 (+11.09%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

06/17/21 JMP Securities
Goldman Sachs price target raised to $425 from $400 at JMP Securities
06/16/21 JPMorgan
Goldman Sachs price target raised to $452 from $351 at JPMorgan
06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

06/29/21 Evercore ISI
Evercore says Morgan Stanley the 'standout' on capital plan among DFAST banks
06/16/21 JPMorgan
Morgan Stanley price target raised to $105 from $85 at JPMorgan
06/09/21 Jefferies
Jefferies starts 'compelling compounder' Morgan Stanley at Buy
06/09/21 Jefferies
Morgan Stanley initiated with a Buy at Jefferies
JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

06/24/21 Cowen
Cowen says vote on first antitrust bill encouraging for big tech
06/24/21 Morgan Stanley
Amazon Prime Day revenue up 7% year-over-year, says Morgan Stanley
06/24/21 Piper Sandler
Amazon Prime Day sales rose 13% over last year, says Piper Sandler
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
F Ford
$14.52 /

-0.25 (-1.69%)

06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
06/22/21 Barclays
Ford price target raised to $17 from $15 at Barclays
06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
SAFO Save Foods
/

+

HOOD Robinhood
/

+

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 18
    Jun
  • 18
    Jun
  • 18
    Jun
  • 17
    Jun
  • 16
    Jun
  • 16
    Jun
  • 17
    Jun
  • 16
    Jun
  • 27
    May
  • 28
    May
  • 27
    May
  • 27
    May
  • 26
    May
  • 26
    May
  • 26
    May
MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

DIDI DiDi
$14.23 /

-2.43 (-14.59%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

WKME WalkMe
$28.83 /

-0.17 (-0.59%)

SAFO Save Foods
/

+

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

HOOD Robinhood
/

+

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

F Ford
$14.52 /

-0.25 (-1.69%)

DIDI DiDi
$14.23 /

-2.43 (-14.59%)

DAWN Day One Biopharmaceuticals
$21.42 /

+2.1899 (+11.39%)

CYT Cyteir Therapeutics
$17.18 /

+0.18 (+1.06%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

MS Morgan Stanley
$84.05 /

-3.86 (-4.39%)

JPM JPMorgan
$147.87 /

-3.92 (-2.58%)

GS Goldman Sachs
$348.74 /

-12.86 (-3.56%)

FIGS Figs
$36.55 /

+0.04 (+0.11%)

F Ford
$14.52 /

-0.25 (-1.69%)

AMZN Amazon.com
$3,486.78 /

-7.155 (-0.20%)

Syndicate
Century Therapeutics opens at $19.50, IPO priced at $20 per share » 12:14
06/18/21
06/18
12:14
06/18/21
12:14
IPSC

Century Therapeutics

/

+

Century Therapeutics is…

Century Therapeutics is developing genetically engineered, iPSC-derived iNK and iT cell products to specifically target hematologic and solid tumor cancers.

ShowHide Related Items >><<
  • 18
    Jun
Syndicate
Century Therapeutics indicated to open at $20, IPO priced at $20 » 11:18
06/18/21
06/18
11:18
06/18/21
11:18
IPSC

Century Therapeutics

/

+

Century Therapeutics…

Century Therapeutics (IPSC) priced 10.55M shares at $20.00, at the top end of the $18.00-$20.00 range. JPMorgan, BofA, SVB Leerink and Piper Sandler are acting as joint book running managers for the offering. Century Therapeutics is developing genetically engineered, iPSC-derived iNK and iT cell products to specifically target hematologic and solid tumor cancers.

ShowHide Related Items >><<
  • 18
    Jun
Syndicate
Century Therapeutics 10.55M share IPO priced at $20.00 » 18:19
06/17/21
06/17
18:19
06/17/21
18:19
IPSC

Century Therapeutics

/

+

The deal priced at top…

The deal priced at top end of $18.00-$20.00 range. JPMorgan, BofA, SVB Leerink and Piper Sandler are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 18
    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.